SubjectWell has acquired PatientCentra to bolster its global patient recruitment for clinical studies, including those for rare diseases and oncology. While the financial terms remain undisclosed, the merger extends SubjectWell’s outreach, previously strong in North America, with PatientCentra’s 15 years of global experience and digital recruitment strategies. This union promises a unified solution for diverse study requirements, enhancing access and enrollment processes for patients worldwide.
SubjectWell, a patient access marketplace connecting individuals with chronic health conditions to healthcare options, has acquired PatientCentra, a company specializing in global patient recruitment and personalized recruitment journeys. Financial details of the acquisition were not disclosed.
This strategic acquisition enhances SubjectWell’s capacity to serve patient recruitment needs for international clinical studies and further extends its capabilities to recruit for rare diseases and oncology-related research.
The combined capabilities of SubjectWell and PatientCentra enable customers to rely on a single company for end-to-end, global patient recruitment support for a range of studies, including vaccine trials, chronic conditions, rare diseases, and oncology research.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
PatientCentra Background
PatientCentra, located in Waltham, MA, offers full-service, global patient recruitment capabilities and an in-house agency for developing tailored, patient-centric recruitment journeys. PatientCentra brings 15 years of experience in delivering digitally enabled patient recruitment programs on five continents, adding to SubjectWell’s strengths in North America.
Source: Hitconsultant